Breakthrough study could give youngest scabies patients better treatment option
NCT ID NCT04332068
Summary
This study tested whether oral ivermectin is safe and effective for treating scabies in young children weighing 5-15kg. Researchers compared the pill to the standard permethrin cream treatment in 240 children. The goal was to gather safety data to potentially expand treatment options for this age group who currently have limited choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfredo da Matta Tropical Dermatology Foundation (FUAM)
Manaus, Brazil
-
Kenya Medical Research Institute
Kisumu, Kenya
-
MRC Unit The Gambia
Banjul, The Gambia
Conditions
Explore the condition pages connected to this study.